Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888287 · ClinicalTrials.gov registry record · NA
Parkinson's Disease Inpatient Clinical Knowledge and Management
A NA study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- NA
- Development phase
- 477
- Enrollment target
NCT03888287: Clinical Trial NA study, sponsored by Hackensack Meridian Health.
NCT03888287 is a NA study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 477 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03888287, a NA study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 477 participants
- Enrollment target
Study Summary
This study will focus on patients with Parkinson's Disease in the adult inpatient units of Hackensack University Medical Center. We are measuring the effect of a Parkinson's Disease Inpatient Clinical Knowledge and Management Program on adherence to Parkinson's Disease medication using a Parkinson's Disease Identification Wrist Band, smartwatch and medication schedule card
Primary Outcome
Clinician's Parkinson's Disease Knowledge Assessment Survey scores before and after the Parkinson's Disease Inpatient Clinical Knowledge and Management Program. A 20-question survey was administered to PD clinicians for a group measurement of PD knowledge. Scores ranged from 0 - 100% and reflected the percentage of clinicians who correctly answered the question. If 70% or more clinicians correctly answered the question, the group was considered knowledgeable on that topic; if \<70% of clinician
Interventions
- DEVICE Watch Rx system
- OTHER Parkinson's Disease Inpatient Clinical Knowledge and Management Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2022-01-03 |
| Phase | NA |
Why NCT03888287 stopped before completion
NCT03888287 is an interventional study that assigns participants to a tested intervention. The registered 477 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which Watch Rx system is the first listed.
NCT03888287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03888287 about?
NCT03888287 is a clinical study titled "Parkinson's Disease Inpatient Clinical Knowledge and Management". This study will focus on patients with Parkinson's Disease in the adult inpatient units of Hackensack University Medical Center. We are measuring the effect of a Parkinson's Disease Inpatient Clinical Knowledge and Management Program on adherence to Parkinson's Disease medication using a Parkinson's...
What is the current status of trial NCT03888287?
This trial is currently terminated. It is a NA study. The enrollment target is 477 participants. The study started on 2018-08-01. Estimated completion is 2022-01-03.
What interventions are being tested in trial NCT03888287?
The interventions under investigation include: Watch Rx system (DEVICE), Parkinson's Disease Inpatient Clinical Knowledge and Management Program (OTHER).
Who is sponsoring clinical trial NCT03888287?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03888287's enrollment target sits among peer trials
477 219th of 2000 higher than 1,781 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI